Epigallocatechin-gallate stimulates NF-E2-related factor and heme oxygenase-1 via caveolin-1 displacement

Journal of Nutritional Biochemistry

Volumn 23, Issue 2, 2012, Pages 163-168

  Zheng, Yuanyuan ^a,b   Morris, Andrew ^c   Sunkara, Manjula ^c   Layne, Joseph ^a,b   Toborek, Michal ^d   Hennig, Bernhard ^a,b  

^a Molecular and Cell Nutrition Laboratory   (United States)

^b Graduate Center for Nutritional Sciences   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Atherosclerosis; Caveolae; EGCG; Endothelial cells; Nrf2

Indexed keywords

BILIRUBIN; CAVEOLIN 1; EPIGALLOCATECHIN GALLATE; HEME OXYGENASE 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MEMBRANE; CYTOSOL; DRUG UPTAKE; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE SILENCING; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; UPREGULATION;

ANIMALS; BILIRUBIN; CATECHIN; CAVEOLAE; CAVEOLIN 1; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HEME OXYGENASE-1; NF-E2-RELATED FACTOR 2; RNA, SMALL INTERFERING; SWINE;

EID: 84855478994     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.12.002     Document Type: Article

References (37)

1. Munoz-Espada A.C., Watkins B.A. Cyanidin attenuates PGE2 production and cyclooxygenase-2 expression in LNCaP human prostate cancer cells. J Nutr Biochem 2006, 17(9):589-596.
2. Kris-Etherton P.M., et al. Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev Nutr 2004, 24:511-538.
3. Sasazuki S., et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 2000, 10(6):401-408.
4. Shenouda S.M., Vita J.A. Effects of flavonoid-containing beverages and EGCG on endothelial function. J Am Coll Nutr 2007, 26(4):366S-372S.
5. Frank P.G., et al. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24(1):98-105.
6. Frank P.G., Pavlides S., Lisanti M.P. Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell Tissue Res 2009, 335(1):41-47.
7. Pelkmans L., Helenius A. Endocytosis via caveolae. Traffic 2002, 3(5):311-320.
8. Matveev S., et al. The role of caveolae and caveolin in vesicle-dependent and vesicle-independent trafficking. Adv Drug Deliv Rev 2001, 49(3):237-250.
9. Zheng Y., et al. Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation. J Nutr Biochem 2009, 20(3):202-209.
10. Yang H.L., et al. Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model. J Transl Med 2009, 7:22.
11. Wu C.C., et al. Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 2006, 78(25):2889-2897.
12. Kim H.P., et al. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J 2004, 18(10):1080-1089.
13. Durante W. Targeting heme oxygenase-1 in vascular disease. Curr Drug Targets 2010, 11(12):1504-1516.
14. Zheng Y., Toborek M., Hennig B. Epigallocatechin gallate-mediated protection against tumor necrosis factor-alpha-induced monocyte chemoattractant protein-1 expression is heme oxygenase-1 dependent. Metabolism 2010, 59(10):1528-1535.
15. Itoh K., Mimura J., Yamamoto M. Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid Redox Signal 2010, 13(11):1665-1678.
16. Siow R.C., Ishii T., Mann G.E. Modulation of antioxidant gene expression by 4-hydroxynonenal: atheroprotective role of the Nrf2/ARE transcription pathway. Redox Rep 2007, 12(1):11-15.
17. Romeo L., et al. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J Am Coll Nutr 2009, 28(Suppl):492S-499S.
18. Hennig B., et al. Exposure to free fatty acid increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis 1984, 4(5):489-497.
19. Lim E.J., et al. Coplanar polychlorinated biphenyl-induced CYP1A1 is regulated through caveolae signaling in vascular endothelial cells. Chem Biol Interact 2008, 176(2-3):71-78.
20. Repetto S., et al. Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism. Biochem Biophys Res Commun 2005, 337(3):849-852.
21. Clark J.E., et al. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 2000, 348(Pt 3):615-619.
22. Sang S., et al. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J Agric Food Chem 2005, 53(24):9478-9484.
23. Dinkova-Kostova A.T., et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 2002, 99(18):11908-11913.
24. Ramesh E., Geraldine P., Thomas P.A. Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis. Chem Biol Interact 2010, 183(1):125-132.
25. Meijering B.D., et al. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res 2009, 104(5):679-687.
26. Patra S.K., et al. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. J Physiol Pharmacol 2008, 59(Suppl 9):217-235.
27. Khan N., et al. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 2006, 66(5):2500-2505.
28. Gonzalez-Gallego J., et al. Fruit polyphenols, immunity and inflammation. Br J Nutr 2010, 104(Suppl 3):S15-S27.
29. Li X.A., Everson W.V., Smart E.J. Caveolae, lipid rafts, and vascular disease. Trends Cardiovasc Med 2005, 15(3):92-96.
30. Majkova Z, M Toborek, B Hennig. The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicants. J Cell Mol Med.
31. Li Q., et al. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch Biochem Biophys 2007, 466(2):250-259.
32. Maniatis N.A., et al. Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ Res 2006, 99(8):870-877.
33. Chung H.T., Pae H.O., Cha Y.N. Role of heme oxygenase-1 in vascular disease. Curr Pharm Des 2008, 14(5):422-428.
34. Lin H.Y., Shen S.C., Chen Y.C. Anti-inflammatory effect of heme oxygenase 1: glycosylation and nitric oxide inhibition in macrophages. J Cell Physiol 2005, 202(2):579-590.
35. Lee T.S., Tsai H.L., Chau L.Y. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2. J Biol Chem 2003, 278(21):19325-19330.
36. Nguyen T., et al. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 2003, 278(7):4536-4541.
37. Li Q., et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 2007, 89(1):169-177.